Las Vegas, NV -- (SBWIRE) -- 10/01/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), NewLead Holdings Ltd (NASDAQ:NEWL), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), FreeSeas Inc. (NASDAQ:FREE)
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) gained volume of 38.85 million shares and the average volume of the stock remained 1.25 million shares. The 52 week range of the stock remained $2.87 - $3.62 and the day range was $2.87 - $3.62.The stock opened the session at $3.44, and closed the session at $3.02. The stock showed a negative performance of -58.29% in previous trading session. Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the treatment of resistant bacterial infections.
Has ACHN Found The Bottom and Ready To Move Up? Find Out Here
In previous session, NewLead Holdings Ltd (NASDAQ:NEWL) traded 24.31 million shares and the average volume of the stock remained 10.72 million shares. The 52 week range of the stock remained $0.07 - $2.73. The stock was a bear and dropped -10.58%, while its closing price stayed at $0.137. The market capitalization of the stock remained 54.36 million. The half-yearly trend of the stock remained negative -78.25%. NewLead Holdings Ltd. (NewLead) is an international shipping company engaged in the transportation of refined products, such as gasoline and jet fuel, and dry bulk goods, such as iron ore, coal and grain. NewLead operates in two segments: wet operations, which consists of tankers transporting several different refined petroleum products simultaneously in segregated, coated cargo tanks, and dry operations, which consists of transportation and handling of bulk cargoes through ownership, operation and trading of vessels.
Has NEWL Found The Bottom And Ready To Gain Momentum? Find Out Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) volume of the stock was 11.38 million shares in the most recent session and the average volume remained 4.49 million shares. The stock plunged -8.98% and finished the prior session at the closing price of $5.27. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
FreeSeas Inc. (NASDAQ:FREE) traded with volume of 8.80 million shares and the average volume of the stock remained 9.30 million shares. The stock decreased -13.78% and finished the trading at $0.669. The market capitalization of the stock remained 440,238. The beta of the stock remained 3.11. FreeSeas Inc. (FreeSeas) is a parent holding company of its ship-owning companies. The Company’s fleet consists of six Handysize vessels and one Handymax vessel that carry a variety of drybulk commodities, including iron ore, grain and coal, which are referred to as bulks, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar and rice, or minor bulks.
Will FREE Get Buyers Even After The Recent Rally? Find Out Here
About Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock readers, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wallstreet. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)